Work

Efficacy and safety of ipilimumab in metastatic melanoma patients surviving more than 2 years following treatment in a phase III trial (MDX010-20)

Year: 2013

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdt291

Authors: D. McDermott, J. Haanen, T.-T. Chen, P. Lorigan, S. O'Day

Institutions: Beth Israel Deaconess Medical Center, The Netherlands Cancer Institute, Bristol-Myers Squibb (United States), The Christie Hospital, The Christie NHS Foundation Trust, Beverly Hills Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2154391127

FWCI: 10.15

Cites: 22

Cited by: 219

Related to: 10